NEW YORK STATE ASSEMBLY MEMORANDUM IN SUPPORT OF LEGISLATION submitted in accordance with Assembly Rule III, Sec 1(f)
BILL NUMBER: A6065
SPONSOR: Rosenthal L TITLE OF BILL:
An act to amend the public health law, in relation to decriminalizing
psilocybin
PURPOSE:
This legislation will decriminalize psilocybin and psilocyn.
SUMMARY OF SPECIFIC PROVISIONS:
Section one amends paragraphs 19, 20, 21, 22, 23, 24, 25, 26, 27, 28,
29, 30, 31, 32, 33, 34, 35, 36, 37 and 38 of subdivision (d) of schedule
I of section 3306 of the public health law, paragraphs 19, 20, 21, 22,
23, and 24 as added by chapter 664 of the laws of 1985, paragraphs 25,
26, 27, 28, 29, and 30 as added by chapter 589 of the laws of 1996,
paragraphs 31 and 32 as added by chapter 457 of the laws of 2006, para-
graphs 33, 34 and 35 as added by chapter 370 of the laws of 2015 and
paragraphs 36, 37 and 38 as added by section 5 of part BB of chapter 57
and the laws of 2018.
Section two establishes the effective date.
JUSTIFICATION:
Psilocybin is a naturally occurring chemical compound produced by
certain species of mushroom. It is the active ingredient in what are
colloquially called "magic mushrooms." In 2018, the United States Food
and Drug Administration designated the use of psilocybin as a "break-
through therapy for treatment-resistant depression," after reviewing the
work of Compass Pathways, which is conducting clinical trials exploring
its use in treating severe depression. One study demonstrated that a
single dose of psilocybin could assist cancer patients in combating
anxiety and dark moods, while others indicated the drug's ability to
help people struggling with substance use disorder, addiction to nico-
tine and anorexia nervosa. Many cities, including Denver, CO, Santa
Cruz, CA, and Oakland, CA, have already decriminalized the use and
possession of psilocybin, and New York should do the same. With the
opportunity to positively affect the lives of millions suffering with
mental health and addiction issues, this bill will decriminalize psilo-
cybin and allow further research into the study of the drug and its
beneficial uses for treatment.
LEGISLATIVE HISTORY:
2019-20: A.10299 - Referred to Health
FISCAL IMPLICATIONS:
Undetermined.
EFFECTIVE DATE:
This act shall take effect immediately.
STATE OF NEW YORK
________________________________________________________________________
6065
2021-2022 Regular Sessions
IN ASSEMBLY
March 8, 2021
___________
Introduced by M. of A. L. ROSENTHAL -- read once and referred to the
Committee on Health
AN ACT to amend the public health law, in relation to decriminalizing
psilocybin
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Paragraphs 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30,
2 31, 32, 33, 34, 35, 36, 37 and 38 of subdivision (d) of schedule I of
3 section 3306 of the public health law, paragraphs 19, 20, 21, 22, 23 and
4 24 as added by chapter 664 of the laws of 1985, paragraphs 25, 26, 27,
5 28, 29 and 30 as added by chapter 589 of the laws of 1996, paragraphs 31
6 and 32 as added by chapter 457 of the laws of 2006, paragraphs 33, 34
7 and 35 as added by chapter 370 of the laws of 2015 and paragraphs 36, 37
8 and 38 as added by section 5 of part BB of chapter 57 of the laws of
9 2018, are amended to read as follows:
10 (19) [Psilocybin.
11 (20) Psilocyn.
12 (21)] Tetrahydrocannabinols. Synthetic equivalents of the substances
13 contained in the plant, or in the resinous extractives of cannabis, sp.
14 and/or synthetic substances, derivatives, and their isomers with similar
15 chemical structure and pharmacological activity such as the following:
16 [/\] delta 1 cis or trans tetrahydrocannabinol, and their optical
17 isomers
18 [/\] delta 6 cis or trans tetrahydrocannabinol, and their optical
19 isomers
20 [/\] delta 3, 4 cis or trans tetrahydrocannabinol, and its optical
21 isomers (since nomenclature of these substances is not internationally
22 standardized, compounds of these structures, regardless of numerical
23 designation of atomic positions covered).
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD00987-02-1
A. 6065 2
1 [(22)] (20) Ethylamine analog of phencyclidine. Some trade or other
2 names: N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl) ethyla-
3 mine, N-(1-phenylcyclohexyl) ethylamine cyclohexamine, PCE.
4 [(23)] (21) Pyrrolidine analog of phencyclidine. Some trade or other
5 names 1-(1-phenylcyclohexyl)-pyrrolidine; PCPy, PHP.
6 [(24)] (22) Thiophene analog of phencyclidine. Some trade or other
7 names: 1-{1-(2-thienyl)-cyclohexyl}-piperidine, 2-thienylanalog of
8 phencyclidine, TPCP, TCP.
9 [(25)] (23) 3,4-methylenedioxymethamphetamine (MDMA).
10 [(26)] (24) 3,4-methylendioxy-N-ethylamphetamine (also known as
11 N-ethyl-alpha-methyl-3,4 (methylenedioxy)) phenethylamine, N-ethyl MDA,
12 MDE, MDEA.
13 [(27)] (25) N-hydroxy-3,4-methylenedioxyamphetamine (also known as
14 N-hydroxy-alpha-methyl-3,4 (methylenedioxy)) phenethylamine, and
15 N-hydroxy MDA.
16 [(28)] (26) 1-{1- (2-thienyl) cyclohexyl} pyrrolidine. Some other
17 names: TCPY.
18 [(29)] (27) Alpha-ethyltryptamine. Some trade or other names:
19 etryptamine; Monase; Alpha-ethyl-1H-indole-3-ethanamine;
20 3- (2-aminobutyl) indole; Alpha-ET or AET.
21 [(30)] (28) 2,5-dimethoxy-4-ethylamphetamine. Some trade or other
22 names: DOET.
23 [(31)] (29) 4-Bromo-2,5-dimethoxyphenethylamine. Some trade or other
24 names: 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl
25 DOB; 2C-B, Nexus.
26 [(32)] (30) 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7), its
27 optical isomers, salts and salts of isomers.
28 [(33)] (31) 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)
29 ethanamine also known as 25I-NBOMe; 2C-I-NBOMe; 25I; or Cimbi-5.
30 [(34)] (32) 2-(4-chloro-2,5-dimethoxyphenyl)-N- (2-methoxybenzyl)
31 ethanamine, also known as 25 CNBOMe; 2C-C-NBOMe; 25C; or Cimbi-82.
32 [(35)] (33) 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- methoxybenzyl)
33 ethanamine, also known as, 25 BNBOMe; 2C-B-NBOMe; Cimbi-36.
34 [(36)] (34) 5-methoxy-N,N-dimethyltryptamine.
35 [(37)] (35) Alpha-methyltryptamine. Some trade or other names: AMT.
36 [(38)] (36) 5-methoxy-N,N-diisopropyltryptamine. Some trade or other
37 names: 5-MeO-DIPT.
38 § 2. This act shall take effect on the ninetieth day after it shall
39 have become a law.
